Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
New glycan arrays discover autoimmunogenic activities of SARS-CoV

New glycan arrays discover autoimmunogenic activities of SARS-CoV

Women with a history of cancer in their family are better off having MRI scans instead of mammograms

Women with a history of cancer in their family are better off having MRI scans instead of mammograms

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Strategic analysis of the breast cancer therapeutics pipeline

Strategic analysis of the breast cancer therapeutics pipeline

New imaging agent will enable doctors to rapidly and accurately detect those hard-to-diagnose appendicitis cases

New imaging agent will enable doctors to rapidly and accurately detect those hard-to-diagnose appendicitis cases

Oxford Therapeutic Antibody Centre receives Manufacturer’s Authorisation

Oxford Therapeutic Antibody Centre receives Manufacturer’s Authorisation

Chemotherapy agents as well as the newest biologic and targeted cancer therapy drugs, can harm a patient’s heart

Chemotherapy agents as well as the newest biologic and targeted cancer therapy drugs, can harm a patient’s heart

Animal vaccine shows potential for the development of human SARS immunisation

Animal vaccine shows potential for the development of human SARS immunisation

University of Cambridge to generate antibodies

University of Cambridge to generate antibodies

Remicade shows improvement in both the arthritis and psoriasis associated with psoriatic arthritis

Remicade shows improvement in both the arthritis and psoriasis associated with psoriatic arthritis

Experimental human monoclonal antibody shows striking benefit in patients with advanced melanoma

Experimental human monoclonal antibody shows striking benefit in patients with advanced melanoma

Drug helps patients with metastatic colorectal cancer

Drug helps patients with metastatic colorectal cancer

Drug to extend lives of colorectal cancer patients

Drug to extend lives of colorectal cancer patients

Accurate and effective new methods for diagnosis of Inflammatory bowel diseases

Accurate and effective new methods for diagnosis of Inflammatory bowel diseases

New method for treating the digestive disease, ulcerative colitis (UC)

New method for treating the digestive disease, ulcerative colitis (UC)

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Trial of antibody for HIV Infection

Trial of antibody for HIV Infection

500,000 patients have now been treated with REMICADE® worldwide

500,000 patients have now been treated with REMICADE® worldwide

DakoCytomation has acquired exclusive worldwide rights to develop and commercialize pharmacogenomic diagnostic tests in the field of oncology

DakoCytomation has acquired exclusive worldwide rights to develop and commercialize pharmacogenomic diagnostic tests in the field of oncology